Search

IndicationsApremilast is indicated for the treatment of adult patients with active psoriatic arthritis and moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Therapeutic ClassDisease-modifying antirheumatic drug..

Premil — Composition & Pharmacology Generic Name: RepaglinideManufacturer: Beximco Pharmaceuticals Ltd.Drug Class: Pharmaceutical AgentDosage Form: Preparation Premil (Repaglinide) is manufactured by Beximco Pharmaceuticals Ltd. for therapeutic use. Indications As directed by a qualified phy..

Premil — Composition & Pharmacology Generic Name: RepaglinideManufacturer: Beximco Pharmaceuticals Ltd.Drug Class: Pharmaceutical AgentDosage Form: Preparation Premil (Repaglinide) is manufactured by Beximco Pharmaceuticals Ltd. for therapeutic use. Indications As directed by a qualified phy..

Premil — Composition & Pharmacology Generic Name: RepaglinideManufacturer: Beximco Pharmaceuticals Ltd.Drug Class: Pharmaceutical AgentDosage Form: Preparation Premil (Repaglinide) is manufactured by Beximco Pharmaceuticals Ltd. for therapeutic use. Indications As directed by a qualified phy..

DescriptionApremilast is an inhibitor of phosphodiesterase 4 (PDE4) enzyme specific for cyclic adenosine monophosphate (cAMP). PDE4 inhibition results in increased intracellular cAMP levels. The specific mechanism by which Apremilast exerts its therapeutic action in psoriatic arthritis patients and ..